MolDX: Biomarkers in Cardiovascular Risk Assessment
J15 · Effective Oct 5, 2015
11 active Medicare policies list 86141, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 5, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JJ · Effective Oct 5, 2015
JM · Effective Oct 5, 2015
J5 · Effective Jun 16, 2016
J8 · Effective Jun 16, 2016
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
8 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 86141 |
|---|---|---|
| Colonoscopy, Colorectal Cancer Screening, and Related Procedures | Aug 1, 2023 | Covered |
| Fetal Fibronectin, Inflammatory Biomarkers, and Salivary Hormone Testing for Preterm Labor | Apr 6, 2023 | Covered |
| Hip Arthroplasty | Nov 20, 2023 | Covered |
| Myalgic Encephalomyelitis - Chronic Fatigue Syndrome (ME/CSF) | Jun 21, 2023 | Covered |
| Policy | Effective | Status of 86141 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease |
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
| Jul 15, 2026 |
| Covered |
| Policy | Effective | Status of 86141 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 86141 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 86141 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |